By successfully completing its first cannabis shipment to Germany, CannaPharmaRX, a newest addition to the worldwide cannabis production sector, has advanced significantly in its operations. This action highlights the company’s developing reputation as a reliable source of high-quality cannabis products and represents a significant turning point in its global expansion strategy. CannaPharmaRX has a production facility in Cremona, Canada, and is able to produce over 6,000 kgs per year.
A move into the German market
At an average price of 1.94 CAD (1,25 EUR) per gram, CannaPharmaRX sent 227.5 kg of its unique cannabis strains to Germany in March 2025. Due in part to the shipment’s positive reception, demand for subsequent deliveries has increased. This accomplishment not only shows how good the company’s products are, but it also establishes CannaPharmaRX as a player in Germany’s developing medical cannabis market.
Germany’s growing patient population and progressive legal framework make it one of Europe’s most promising cannabis marketplaces. By entering this market, CannaPharmaRX is strengthening its position internationally, generating new revenue streams, and capturing a high-value, long-term opportunity.
CannaPharmaRX isn’t sitting back and enjoying its success. A second shipment to Germany is currently planned by the company and is expected to arrive in June 2025. It is anticipated that this shipment would weigh about 241 kg. THC concentration will determine pricing; strains with less than 21% THC will cost 1.82 CAD (1,15 EUR) per gram, while products with more than 21% THC would cost 2.04 CAD (1,30 EUR) per gram. Strong market demand and the high caliber of the company’s cannabis products are reflected in these costs.
A history of global achievements
CannaPharmaRX expands its excellent export history to Israel by entering the German market. The business shipped more than 660 kg to Israel four times since 2024. Every shipment shows increased volumes and higher average prices per gram, indicating steady product quality and growing demand. The corporation delivered nearly 119 kilograms to Israel in April 2025 at an average price of 1.90 CAD (1,20 EUR) per gram.
CannaPharmaRX has served as an intermediary for other Canadian producers in addition to its own goods, enabling the transfer of 127.43 kg to Israeli customers in its third and fourth shipments. CannaPharmaRX boosts its revenue and it also becomes a key global cannabis trading hub.
Strategic development and capacity growth
Currently, CannaPharmaRX is only using five of its ten available grow rooms at its cultivation facility. However, the business has planned investments for 2025 in order to build a new drying room and bring all ten rooms online. These improvements will greatly increase production capacity and enhance post-harvest processing, resulting in even higher-quality products. The company’s estimations indicate that each grow room will produce 60 to 80 kg each month. Currently, five rooms are in operation. The average monthly production is 150 kg. Full operational capability could lead to a significant increase in output and revenue what aligns with the company’s goals for global expansion.
CannaPharmaRX’s debut in the German cannabis market was more than a commercial success. It shows the company’s high standards, global potential, and strategic vision. CannaPharmaRX is on track to become a major global supplier in the cannabis sector. It is preparing for its second shipment to Germany and continues to grow its business.
CannaPharmaRX is leading the way in global cannabis commerce. They focus on strategic cultivation and international partnerships. Their list of satisfied customers is growing worldwide.